Vanda Pharmaceuticals | VNDA - Eps Gewinn Pro Aktie





Eps Veränderung Datum
Acadia Pharmaceuticals USD 0.31 0.13 2026-09
Agios Pharmaceuticals USD -1.09 0.6 2026-09
Akebia Therapeutics USD -0.04 0.04 2025-12
Alnylam Pharmaceuticals USD 16.26 14.42 2026-09
Anika Therapeutics USD 0.13 0.35 2025-12
Arrowhead Research USD -1.36 0.43 2026-06
AstraZeneca USD 2.79 0.16 2026-09
Bristol-Myers Squibb USD 1.35 0.69 2026-09
Eli Lilly USD 7.48 0.9 2026-09
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Halozyme Therapeutics USD 2.39 0.11 2026-09
Heron Therapeutics USD -0.02 0.02 2025-12
Insmed USD -0.46 0.4 2026-09
J&J USD 2.7 0.2 2026-09
Lexicon Pharmaceuticals USD -0.04 0.01 2025-12
Ligand Pharmaceuticals USD 2.67 0.3 2026-09
Merck USD 2.49 2.62 2026-09
Minerva Neurosciences USD -0.56 3.53 2024-12
Moderna USD 0.38 2.35 2026-09
Novartis USD 0.63 1.36 2026-09
Pfizer USD 0.87 0.1 2026-09
PTC Therapeutics USD -0.62 1.54 2026-09
Puma Biotechnology USD 0.41 0.5 2024-09
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 3.55 1.46 2026-09
Takeda JPY 116.95 45.3 2026-09
Teva Pharmaceutical Industries USD 0.79 0.73 2026-09
Ultragenyx Pharmaceutical USD -1.16 0.26 2026-09
Vanda Pharmaceuticals USD -0.09 0 2024-12
Veracyte USD 0.51 0.03 2026-09